DPP9 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "DPP9" in English language version.

refsWebsite

Global rank English rank

15nih.gov

4^th place

6doi.org

2^nd place

3harvard.edu

18^th place

17^th place

2ensembl.org

1,626^th place

1,007^th place

1handle.net

102^nd place

76^th place

1omim.org

4,380^th place

4,305^th place

doi.org (Global: 2^nd place; English: 2^nd place)

Hollingsworth LR, Sharif H, Griswold AR, Fontana P, Mintseris J, Dagbay KB, et al. (April 2021). "DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation". Nature. 592 (7856): 778–783. Bibcode:2021Natur.592..778H. doi:10.1038/s41586-021-03350-4. PMC 8299537. PMID 33731932.
Huang M, Zhang X, Toh GA, Gong Q, Wang J, Han Z, et al. (April 2021). "Structural and biochemical mechanisms of NLRP1 inhibition by DPP9". Nature. 592 (7856): 773–777. Bibcode:2021Natur.592..773H. doi:10.1038/s41586-021-03320-w. PMC 8081665. PMID 33731929.
Sharif H, Hollingsworth LR, Griswold AR, Hsiao JC, Wang Q, Bachovchin DA, et al. (July 2021). "Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment". Immunity. 54 (7): 1392–1404.e10. doi:10.1016/j.immuni.2021.04.024. PMC 8423358. PMID 34019797.
Harapas CR, Robinson KS, Lay K, Wong J, Moreno Traspas R, Nabavizadeh N, et al. (September 2022). "DPP9 deficiency: An inflammasomopathy that can be rescued by lowering NLRP1/IL-1 signaling". Science Immunology. 7 (75) eabi4611. doi:10.1126/sciimmunol.abi4611. hdl:10754/681562. PMC 9844213. PMID 36112693.
Zhong FL, Robinson K, Teo DE, Tan KY, Lim C, Harapas CR, et al. (December 2018). "Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding". The Journal of Biological Chemistry. 293 (49): 18864–18878. doi:10.1074/jbc.RA118.004350. PMC 6295727. PMID 30291141.
Ferreira LC, Gomes CE, Rodrigues-Neto JF, Jeronimo SM (December 2022). "Genome-wide association studies of COVID-19: Connecting the dots". Infection, Genetics and Evolution. 106 105379. Bibcode:2022InfGE.10605379F. doi:10.1016/j.meegid.2022.105379. PMC 9584840. PMID 36280088.

ensembl.org (Global: 1,626^th place; English: 1,007^th place)

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000142002 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000001229 – Ensembl, May 2017

handle.net (Global: 102^nd place; English: 76^th place)

hdl.handle.net

Harapas CR, Robinson KS, Lay K, Wong J, Moreno Traspas R, Nabavizadeh N, et al. (September 2022). "DPP9 deficiency: An inflammasomopathy that can be rescued by lowering NLRP1/IL-1 signaling". Science Immunology. 7 (75) eabi4611. doi:10.1126/sciimmunol.abi4611. hdl:10754/681562. PMC 9844213. PMID 36112693.

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

Hollingsworth LR, Sharif H, Griswold AR, Fontana P, Mintseris J, Dagbay KB, et al. (April 2021). "DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation". Nature. 592 (7856): 778–783. Bibcode:2021Natur.592..778H. doi:10.1038/s41586-021-03350-4. PMC 8299537. PMID 33731932.
Huang M, Zhang X, Toh GA, Gong Q, Wang J, Han Z, et al. (April 2021). "Structural and biochemical mechanisms of NLRP1 inhibition by DPP9". Nature. 592 (7856): 773–777. Bibcode:2021Natur.592..773H. doi:10.1038/s41586-021-03320-w. PMC 8081665. PMID 33731929.
Ferreira LC, Gomes CE, Rodrigues-Neto JF, Jeronimo SM (December 2022). "Genome-wide association studies of COVID-19: Connecting the dots". Infection, Genetics and Evolution. 106 105379. Bibcode:2022InfGE.10605379F. doi:10.1016/j.meegid.2022.105379. PMC 9584840. PMID 36280088.

nih.gov (Global: 4^th place; English: 4^th place)

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: DPP9 dipeptidyl-peptidase 9".
Hollingsworth LR, Sharif H, Griswold AR, Fontana P, Mintseris J, Dagbay KB, et al. (April 2021). "DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation". Nature. 592 (7856): 778–783. Bibcode:2021Natur.592..778H. doi:10.1038/s41586-021-03350-4. PMC 8299537. PMID 33731932.
Huang M, Zhang X, Toh GA, Gong Q, Wang J, Han Z, et al. (April 2021). "Structural and biochemical mechanisms of NLRP1 inhibition by DPP9". Nature. 592 (7856): 773–777. Bibcode:2021Natur.592..773H. doi:10.1038/s41586-021-03320-w. PMC 8081665. PMID 33731929.
Sharif H, Hollingsworth LR, Griswold AR, Hsiao JC, Wang Q, Bachovchin DA, et al. (July 2021). "Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment". Immunity. 54 (7): 1392–1404.e10. doi:10.1016/j.immuni.2021.04.024. PMC 8423358. PMID 34019797.
Harapas CR, Robinson KS, Lay K, Wong J, Moreno Traspas R, Nabavizadeh N, et al. (September 2022). "DPP9 deficiency: An inflammasomopathy that can be rescued by lowering NLRP1/IL-1 signaling". Science Immunology. 7 (75) eabi4611. doi:10.1126/sciimmunol.abi4611. hdl:10754/681562. PMC 9844213. PMID 36112693.
Zhong FL, Robinson K, Teo DE, Tan KY, Lim C, Harapas CR, et al. (December 2018). "Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding". The Journal of Biological Chemistry. 293 (49): 18864–18878. doi:10.1074/jbc.RA118.004350. PMC 6295727. PMID 30291141.
Ferreira LC, Gomes CE, Rodrigues-Neto JF, Jeronimo SM (December 2022). "Genome-wide association studies of COVID-19: Connecting the dots". Infection, Genetics and Evolution. 106 105379. Bibcode:2022InfGE.10605379F. doi:10.1016/j.meegid.2022.105379. PMC 9584840. PMID 36280088.

pubmed.ncbi.nlm.nih.gov

Hollingsworth LR, Sharif H, Griswold AR, Fontana P, Mintseris J, Dagbay KB, et al. (April 2021). "DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation". Nature. 592 (7856): 778–783. Bibcode:2021Natur.592..778H. doi:10.1038/s41586-021-03350-4. PMC 8299537. PMID 33731932.
Huang M, Zhang X, Toh GA, Gong Q, Wang J, Han Z, et al. (April 2021). "Structural and biochemical mechanisms of NLRP1 inhibition by DPP9". Nature. 592 (7856): 773–777. Bibcode:2021Natur.592..773H. doi:10.1038/s41586-021-03320-w. PMC 8081665. PMID 33731929.
Sharif H, Hollingsworth LR, Griswold AR, Hsiao JC, Wang Q, Bachovchin DA, et al. (July 2021). "Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment". Immunity. 54 (7): 1392–1404.e10. doi:10.1016/j.immuni.2021.04.024. PMC 8423358. PMID 34019797.
Harapas CR, Robinson KS, Lay K, Wong J, Moreno Traspas R, Nabavizadeh N, et al. (September 2022). "DPP9 deficiency: An inflammasomopathy that can be rescued by lowering NLRP1/IL-1 signaling". Science Immunology. 7 (75) eabi4611. doi:10.1126/sciimmunol.abi4611. hdl:10754/681562. PMC 9844213. PMID 36112693.
Zhong FL, Robinson K, Teo DE, Tan KY, Lim C, Harapas CR, et al. (December 2018). "Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding". The Journal of Biological Chemistry. 293 (49): 18864–18878. doi:10.1074/jbc.RA118.004350. PMC 6295727. PMID 30291141.
Ferreira LC, Gomes CE, Rodrigues-Neto JF, Jeronimo SM (December 2022). "Genome-wide association studies of COVID-19: Connecting the dots". Infection, Genetics and Evolution. 106 105379. Bibcode:2022InfGE.10605379F. doi:10.1016/j.meegid.2022.105379. PMC 9584840. PMID 36280088.

omim.org (Global: 4,380^th place; English: 4,305^th place)

"Autoinflammation With Arthritis and Dyskeratosis; AIADK". Online Mendelian Inheritance in Man. 617388.

DPP9 (English Wikipedia)

doi.org (Global: 2nd place; English: 2nd place)

ensembl.org (Global: 1,626th place; English: 1,007th place)